A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension
Clinical trial NCT00811018 · TERMINATED
Trial details
- NCT number
- NCT00811018
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Primary completion
- 2011-07-01
- Enrollment
- 1192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.